IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

NCT05941741 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Immune Checkpoint Inhibitor
Radiotherapy
Chemotherapy

Interventions

RADIATION: Intensity Modulated Radiation Therapy
DRUG: Chemotherapy
BIOLOGICAL: Immune checkpoint inhibitor
RADIATION: Low-dose radiotherapy

Sponsor

Sun Yat-sen University